CogstateFRA:C4B +1.82%69 Days Inventory is 0.00 as of Dec. 2025. GuruFocus rates FRA:C4B with a GF Score™ of 69/100 and a GF Value™ of €1.35 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 497 Healthcare Providers & Services companies, Cogstate ranks worse than 201207.04% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Cogstate's Average Total Inventories for the
six
months ended in Dec. 2025 was €0.00 Mil. Cogstate's Cost of Goods Sold for the
six
months ended in Dec. 2025 was €10.85 Mil.
Hence, Cogstate's Days Inventory for the
six
months ended in Dec. 2025 was 0.00.
The historical rank and industry rank for Cogstate's Days Inventory or its related term are showing as below:
FRA:C4B's Days Inventory is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 30.42 * Ranked among companies with meaningful Days Inventory only.
Cogstate's Days Inventory
stayed the same
from Dec. 2024 (0.00) to Dec. 2025 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cogstate's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.00.
Cogstate (FRA:C4B) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cogstate's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cogstate's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Cogstate Days Inventory Related Terms
Cogstate Days Inventory Historical Data
* Premium members only.
The historical data trend for Cogstate's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:C4B vs VEEV, BTSG, TEM: Days Inventory Comparison
For the Health Information Services subindustry, Cogstate's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cogstate Days Inventory vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cogstate's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cogstate's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cogstate (FRA:C4B) has a Days Inventory of 0.00 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cogstate and its competitors. According to the industry distribution chart, Cogstate ranks #999999 out of 497 companies in the Healthcare Providers & Services industry.
Is Cogstate's Days Inventory too high?
Cogstate's current Days Inventory is 0.00. Based on the distribution chart, Cogstate ranks #999999 out of 497 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Cogstate has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cogstate's Days Inventory compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Cogstate ranks #999999 out of 497 companies for Days Inventory. This places Cogstate in the lower half of its industry. The industry median Days Inventory is 30.42. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 30.42, based on 497 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cogstate and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 30.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cogstate's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogstate stock overvalued right now?
Based on GuruFocus' analysis, Cogstate (FRA:C4B) is currently considered Modestly Overvalued. The stock's GF Value™ is €1.35, compared to a current price of €1.68 — trading 24.4% above its estimated fair value. The current Days Inventory is 0.00. Cogstate's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Cogstate (FRA:C4B), the current Days Inventory is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cogstate (FRA:C4B) Overvalued in 2026?
Based on GuruFocus' analysis, Cogstate stock appears to be overvalued.
The current stock price of €1.68 is trading 24.4% above its estimated GF Value™ of €1.35.
GuruFocus considers Cogstate to be Modestly Overvalued.
Key valuation signals for FRA:C4B:
Days Inventory: 0.00
GF Value™: €1.35 vs. price of €1.68 (24.4% above fair value)
No single metric tells the full story. See the FRA:C4B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
69GF Score
Get the complete analysis for FRA:C4B
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:C4B has been successfully added to your 
